FDA Approves Embryonic Stem Cell Trial In Humans

Biotech company Geron Corp. will conduct a human clinical trial on patients with spinal cord injuries, using a federally approved line of embryonic stem cells. The approval is the first of its kind in the world. Stem cell experts discuss the significance of the decision.


Thomas Okarma, president and CEO, Geron Corporation, Menlo Park, Calif.

Sean J. Morrison, director, University of Michigan Center for Stem Cell Biology, Ann Arbor, Mich.



Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.